Efficacy and safety of I.v. alteplase therapy up to 4.5 hours after acute ischemic stroke onset

Jenna L. Otwell; Haley M. Phillippe; Kelly S. Dixon

首页> 外文期刊>American Journal of Health-System Pharmacy >Efficacy and safety of I.v. alteplase therapy up to 4.5 hours after acute ischemic stroke onset

【24h】

Efficacy and safety of I.v. alteplase therapy up to 4.5 hours after acute ischemic stroke onset

机译：I.v.的功效和安全性急性缺血性中风发作后长达4.5小时的阿替普酶治疗

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Evidence supports the safety and rnefficacy of I.v. alteplase administration to eligible patients within 4.5 rnhours of AIS symptom onset.

机译：证据支持静脉输液的安全性和有效性。在AIS症状发作4.5个小时内向合格患者服用阿替普酶。

著录项

来源
《American Journal of Health-System Pharmacy》 |2010年第13期|P.1070-1074|共5页
作者
Jenna L. Otwell; Haley M. Phillippe; Kelly S. Dixon;
展开▼
作者单位

East Alabama Medical Center and Harrison School of Pharmacy, Auburn University, Opelika, AL;

The Harrison School of Pharmacy, Auburn University, 114 Simmons Drive SE, Owens Cross Roads, AL 35763;

Neurology Intensive Care Clinical Pharmacist, Huntsville Hospital, Huntsville, AL;

展开▼
收录信息美国《科学引文索引》(SCI);美国《化学文摘》(CA);
原文格式 PDF
正文语种 eng
中图分类
关键词

相似文献

外文文献
中文文献
专利

1. Recombinant tissue-type plasminogen activator (Alteplase) for ischemic stroke 3 to 5 hours after symptom onset. The ATLANTIS Study: a randomized controlled trial. Alteplase Thrombolysis for Acute Noninterventional Therapy in Ischemic Stroke (see comm [J] . Clark WM, Wissman S, Albers GW, JAMA: the Journal of the American Medical Association . 1999,第21期

机译：症状发作后3至5个小时的重组组织型纤溶酶原激活剂（阿替普酶），用于缺血性中风。 ATLANTIS研究：一项随机对照试验。阿替普酶溶栓治疗缺血性卒中的急性非介入治疗（请参阅comm
2. Thrombolysis at 3-4.5 Hours after Acute Ischemic Stroke Onset - Evidence from the Canadian Alteplase for Stroke Effectiveness Study (CASES) Registry. [J] . Shobha N, Buchan AM, Hill MD Cerebrovascular diseases . 2011,第3期

机译：急性缺血性中风发作后3-4.5小时的溶栓-来自加拿大Alteplase中风有效性研究（CASES）注册表的证据。
3. Update on thrombolysis beyond 4.5 hours registry in Indonesia: Efficacy and safety of low dose alteplase within 4.5 to 6 hours of onset [J] . M. Kurniawan, S. Harris, A. Rasyid, Journal of the Neurological Sciences: Official Bulletin of the World Federation of Neurology . 2017,第期

机译：在印度尼西亚的4.5小时注册表上的溶栓溶解：低剂量Alteplase的疗效和安全性在4.5至6小时内
4. Transcranial near infrared laser therapy (NILT) to treat acute ischemic stroke: a review of efficacy, safety and possible mechanism of action derived from rabbit embolic stroke studies [C] . Paul A. Lapchak, Jackson Streeter, Luis De Taboada Mechanisms for low-light therapy V . 2010

机译：经颅近红外激光治疗急性缺血性中风：兔栓塞性中风研究的疗效，安全性和可能的作用机制综述
5. The role of iron-induced oxidative stress in acute ischemic stroke and the potential role for fasciculations in their therapy. [D] . Mehta, Shyamal H. 2003

机译：铁诱导的氧化应激在急性缺血性卒中中的作用以及絮凝剂在其治疗中的潜在作用。
6. Efficacy and safety of tissue plasminogen activator 3 to 4.5 hours after acute ischemic stroke: a meta-analysis [O] . Maarten G. Lansberg, Erich Bluhmki, Vincent N. Thijs -1

机译：组织纤溶酶原激活剂3至4.5小时后的疗效和安全性急性缺血性卒中：Meta分析
7. Results of Intravenous Thrombolysis Within 4.5 to 6 Hours and Updated Results Within 3 to 4.5 Hours of Onset of Acute Ischemic Stroke Recorded in the Safe Implementation of Treatment in Stroke International Stroke Thrombolysis Register (SITS-ISTR) An Observational Study [O] . N. Ahmed, L. Kellert, K.r. Lees, 2013

机译：安全卒中国际卒中国际溶栓治疗记录（SITS-ISTR）中记录的急性缺血性卒中发作后4.5至6小时内静脉溶栓的结果和3至4.5小时内更新的结果

Efficacy and safety of I.v. alteplase therapy up to 4.5 hours after acute ischemic stroke onset

摘要

著录项

相似文献

相关主题

期刊订阅